Rett Syndrome Completed Phase 2 Trials for Blarcamesine (DB05592)

Also known as: Rett's Syndrome / Rett's Disorder / RTT / Rett Disorder / Rett's disorder (disorder)

IndicationStatusPhase
DBCOND0002561 (Rett Syndrome)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03758924Study of ANAVEX2-73 in Patients With Rett SyndromeTreatment